8th Annual Conference on Head and Neck Cancer

描述(申请人提供)：第八届头颈部癌症国际会议将于2012年7月21-25日在加拿大安大略省多伦多举行，旨在促进从业者、受训人员和研究人员之间的讨论，重点是协作、多学科治疗和康复如何为头颈部癌症患者带来最佳的肿瘤学、功能和生活质量结果。美国头颈癌症协会每四年主办一次会议，来自四个专业的1500多名与会者(2008年有2000名与会者)参加了这次会议，这些专业代表了医学肿瘤学、放射肿瘤学、放射学和头颈外科等学科，以确保专业内部和专业之间的教育互动，以加强多学科合作关系。会议的目标包括：i)进一步了解和确定我们对头颈部癌症护理的理解中存在的差距，并促进在所代表的多个学科内部和之间进行这些领域的研究；ii)认识到护士、言语病理学家、听力科医生、营养师、社会工作者、疼痛专科医生、心理健康从业者、物理治疗师、牙科肿瘤学家在实现最大功能结果和适当的功能评估以及报告新治疗计划的功能结果方面所发挥的重要作用，以及iii)熟悉正在帮助我们更好地了解头颈部癌症的发病机制和治疗的新兴研究突破。总体而言，会议旨在促进从业者、受训者和研究人员之间的讨论，重点是协作、多学科的治疗和康复如何能够为Head和Head-And带来最佳的肿瘤、功能和生活质量结果。 宫颈癌患者。我们在这项申请中申请资金是为了1)尽可能公平地向世界各地的头颈肿瘤学从业者传播信息，使他们的患者可能从该领域的最新发展中受益；2)确保初级调查人员、住院医生、研究员和医学生有机会；以及3)允许来自世界各地的参与者，包括少数族裔和来自发展中国家的代表。 与公共卫生相关：第八届头颈部癌症国际会议是每四年举行一次的系列会议中的下一次。国际会议是最重要的国际跨学科会议，集中在一次会议上，讨论与头颈癌有关的主题。这些主题包括分子遗传学、肿瘤细胞生物学、免疫学、基因治疗、器官保留外科、放射和成像、放射治疗、化疗、化学预防、重建外科和生活质量问题。会议旨在促进从业者、实习生和研究人员之间的讨论，重点是协作、多学科的治疗和康复如何能够为Head和Head带来最佳的肿瘤、功能和生活质量结果。 2)将临床研究人员、遗传学家、免疫学家以及分子和细胞生物学家聚集在一起，分享头颈部癌症的最新进展，确定未来研究的必要领域，并将这些信息传播给相关领域更大的研究人员社区。在一个行业支持减少的时代，需要资金来支持我们的专业人员--受训人员、初级调查人员、少数族裔和国际参与者--未来的差旅费用。

DESCRIPTION (provided by applicant): The 8th International Conference on Head and Neck Cancer to be held July 21-25, 2012 in Toronto, Ontario, Canada is designed to facilitate discussion among practitioners, trainees, and researchers with an emphasis on how collaborative, multi-disciplinary treatment and rehabilitation can lead to the best oncologic, functional and quality of life outcomes for head and neck cancer patients. The American Head and Neck Cancer sponsors this meeting every four years with participation of over 1500 attendees (2000 attendees in 2008) from four specialties representing the disciplines of medical oncology radiation oncology, radiology and head and neck surgery in order to ensure educational interaction within and between specialties that can strengthen multi-disciplinary collaborative relationships. Objectives for the meeting include i) to further understanding and identify gaps in our understanding of Head and Neck Cancer care and foster research in those areas within and between the multiple disciplines represented; ii) to recognize the important role of nurses, speech pathologists, audiologists, nutritionists, social workers, pain specialists, mental health practitioners, physical therapists, dental oncologists in achieving maximal functional outcomes and proper functional assessment and reporting of functional results of new treatments programs, and iii) to provide familiarity with emerging research breakthroughs that are helping us to better understand the pathogenesis and treatment of head and neck cancer. Overall, the conference is designed to facilitate discussion among practitioners, trainees, and researchers with an emphasis on how collaborative, multi-disciplinary treatment and rehabilitation can lead to the best oncologic, functional and quality of life outcomes for head and neck cancer patients. We request funds in this application in order to 1) disseminate information as equitably as possible to practitioners of head and neck oncology around the world so that their patients may potentially benefit from the most current developments in the field; 2) ensure opportunity for junior investigators, residents, fellows and medical students; and 3) allow participants from around the world including minorities and representatives from developing nations. PUBLIC HEALTH RELEVANCE: The 8th International Conference on Head and Neck Cancer is the next scheduled conference in a series held every four years. The International Conferences are the most important international interdisciplinary conferences focused, in a single meeting, on topics related to head and neck cancer. These topics include molecular genetics, tumor cell biology, immunology, gene therapy, organ-sparing surgery, radiology and imaging, radiotherapy, chemotherapy, chemoprevention, reconstructive surgery, and quality of life issues. The conference is designed 1) to facilitate discussion among practitioners, trainees, and researchers with an emphasis on how collaborative, multi-disciplinary treatment and rehabilitation can lead to the best oncologic, functional and quality of life outcomes for head and neck cancer patients; 2) to bring together clinical investigators, geneticists, immunologists, and molecular and cellular biologists to share recent advances in head and neck cancer, identify needed areas of future research and disseminate this information to the larger community of investigators in related fields. In an era of declining industry support, funds are requested to support travel expenses for the future of our specialty - trainees, junior investigators, minoritie and international participants.